# OnCo record nct05365178 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05365178/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05365178", "NCT05365178" ;
  schema:name "To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer"@en ;
  schema:description "A phase 3 trial testing TQB3616 in HR-positive / HER2-negative breast cancer, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05365178/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05365178> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2022-07-01" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:drugs <https://onco.cc/drugs/tqb3616/> ;
  onco:companies <https://onco.cc/companies/sino-biopharm/> .